Red cell distribution width/platelet ratio estimates the 3-year risk of decompensation in Metabolic Dysfunction-Associated Steatotic Liver Disease-induced cirrhosis

Figure 6 Adjusted odds ratios for non-invasive tools on the first decompensation event’s occurrence. ^aP = 0.02. RPR: Red cell distribution width to platelet ratio; ALBI: Albumin-Bilirubin; FIB-4: Fibrosis-4; MELD: Model for End-Stage Liver Disease; LSM: Liver Stiffness Measurement; OR: Odds ratio.